케이엠제약
225430KOSDAQ기타 화학제품 제조업51.1 / 100
Reference Date: 2026-07-24
Company InformationBased on 2025 Annual Report
Business Overview
KEM Pharmaceuticals specializes in oral care, beauty care, and daily necessities, offering a wide range of products such as children's and adult toothpaste, shampoo, body wash, and anti-wrinkle skincare. Its flagship brands, 'Pororo Friends' and 'Kkoma Bus Taeyo,' account for approximately 33.4% of sales, with active OEM/ODM business. The company aims to expand its domestic and international distribution channels and grow into a comprehensive daily necessities company by maintaining high-quality products.
Number of Employees
63people
Average Salary
42.8M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Well below industry avg
2.7x industry avg (risky)
Avg ▼4.0% (2-year basis)
Avg ▼74.7% (2-year basis)
Avg ROE -10.0% (declining, 3yr)
Detailed News Sentiment
- Positive"꾸준한 나눔 실천"?케이엠제약, 16년간 누적 기부액 5억 넘어서
케이엠제약의 지속적인 사회공헌 활동으로 인한 긍정적 이미지 제고.
- Positive케이엠제약, 뽀로로 잇는 ’해치’ 캐릭터 치약·칫솔 라이선스 확보
케이엠제약이 글로벌 마케팅에서 '해치' 캐릭터를 활용해 새로운 성장 동력을 모색함으로써 긍정적인 시장 반응을 기대.
- Positive케이엠제약, 백승호 대표 참여 10억 규모 3자배정 유증...“책임경영...
케이엠제약의 백승호 대표가 사재를 출연하여 대규모 유증을 통해 책임경영을 강화하고 신규 사업 투자를 확대할 계획이다.
Detailed Momentum
52w mid range (43%)
1m -15.62% (strong drop)
Volume flat
Detailed Disclosure
- Neutral주식등의대량보유상황보고서(일반)2026-07-20
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-20
- Positive주요사항보고서(유상증자결정)2026-07-14
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-08
- Neutral주식등의대량보유상황보고서(일반)2026-07-08
